Drugs & Pharmacology Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Integrating pharmacists into aged care facilities to improve the quality use of medicine (PiRACF Study): protocol for a cluster randomised controlled trial
DiscussionThe results of this study will provide information on clinical and economic outcomes of a model that integrates on-site pharmacists into Australian residential aged care facilities. The results will provide policymakers with recommendations relevant to further implementation of this model.Trial registrationACTRN12620000430932. Registered on 1 April 2020 with ANZCTR (Source: Trials)
Source: Trials - June 11, 2021 Category: Research Source Type: clinical trials
A Phase I, Single Center, Open-label Clinical Pharmacology Study to Evaluate the Effect of Tipifarnib on Cardiac Safety in Subjects With Advanced Solid Malignancies
Condition: Advanced Solid Tumor Intervention: Drug: Tipifarnib Sponsor: Kura Oncology, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2021 Category: Research Source Type: clinical trials
Systems Pharmacology Approach to Uncontrolled Pediatric Asthma
Conditions: Pediatric Asthma; Uncontrolled Asthma Intervention: Sponsors: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); University of Maribor, Maribor, Slovenia.; University Children's Hospital, University of Regensburg, Regensburg, Germany; Universidad de La Laguna, San Cristóbal de La Laguna, Santa Cruz de Tenerife, Spain.; Univ ersity of the Basque Country (UPV/EHU), San Sebastián, Spain.; Hospital Universitario Donostia, San Sebastián, Spain.; Instituto de Salud Carlos III, Madrid, Comunidad de Madrid, Spain.; Utrecht University, Utrecht, the Netherland...
Source: ClinicalTrials.gov - April 29, 2021 Category: Research Source Type: clinical trials
A Phase I, Single Center, Open-label Clinical Pharmacology Study to Evaluate the Effect of Tipifarnib on Cardiac Safety in Subjects With Advanced Solid Malignancies
Condition: Advanced Solid Tumor Intervention: Drug: Tipifarnib Sponsor: Kura Oncology, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2021 Category: Research Source Type: clinical trials
Systems Pharmacology Approach to Uncontrolled Pediatric Asthma
Conditions: Pediatric Asthma; Uncontrolled Asthma Intervention: Sponsors: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); University of Maribor, Maribor, Slovenia.; University Children's Hospital, University of Regensburg, Regensburg, Germany; Universidad de La Laguna, San Cristóbal de La Laguna, Santa Cruz de Tenerife, Spain.; Univ ersity of the Basque Country (UPV/EHU), San Sebastián, Spain.; Hospital Universitario Donostia, San Sebastián, Spain.; Instituto de Salud Carlos III, Madrid, Comunidad de Madrid, Spain.; Utrecht University, Utrecht, the Netherland...
Source: ClinicalTrials.gov - April 29, 2021 Category: Research Source Type: clinical trials
A Phase I, Single Center, Open-label Clinical Pharmacology Study to Evaluate the Effect of Tipifarnib on Cardiac Safety in Subjects With Advanced Solid Malignancies
Condition: Advanced Solid Tumor Intervention: Drug: Tipifarnib Sponsor: Kura Oncology, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2021 Category: Research Source Type: clinical trials
Systems Pharmacology Approach to Uncontrolled Pediatric Asthma
Conditions: Pediatric Asthma; Uncontrolled Asthma Intervention: Sponsors: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); University of Maribor, Maribor, Slovenia.; University Children's Hospital, University of Regensburg, Regensburg, Germany; Universidad de La Laguna, San Cristóbal de La Laguna, Santa Cruz de Tenerife, Spain.; Univ ersity of the Basque Country (UPV/EHU), San Sebastián, Spain.; Hospital Universitario Donostia, San Sebastián, Spain.; Instituto de Salud Carlos III, Madrid, Comunidad de Madrid, Spain.; Utrecht University, Utrecht, the Netherland...
Source: ClinicalTrials.gov - April 29, 2021 Category: Research Source Type: clinical trials
A Phase I, Single Center, Open-label Clinical Pharmacology Study to Evaluate the Effect of Tipifarnib on Cardiac Safety in Subjects With Advanced Solid Malignancies
Condition: Advanced Solid Tumor Intervention: Drug: Tipifarnib Sponsor: Kura Oncology, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2021 Category: Research Source Type: clinical trials
Systems Pharmacology Approach to Uncontrolled Pediatric Asthma
Conditions: Pediatric Asthma; Uncontrolled Asthma Intervention: Sponsors: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); University of Maribor, Maribor, Slovenia.; University Children's Hospital, University of Regensburg, Regensburg, Germany; Universidad de La Laguna, San Cristóbal de La Laguna, Santa Cruz de Tenerife, Spain.; Univ ersity of the Basque Country (UPV/EHU), San Sebastián, Spain.; Hospital Universitario Donostia, San Sebastián, Spain.; Instituto de Salud Carlos III, Madrid, Comunidad de Madrid, Spain.; Utrecht University, Utrecht, the Netherland...
Source: ClinicalTrials.gov - April 29, 2021 Category: Research Source Type: clinical trials
